Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Total Assets

$106.22M

Quarterly · Period ending: · USD

LCTX logo

LCTX Total Assets

Latest reported$112.58M
LCTX FY Total Assets ($4.80M → $112.58M)
High-resolution chart · PNG

LCTX total assets history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Total Assets — Annual fiscal periods (USD)
Period endingTotal Assets (USD)
112,584,000
113,218,000
101,019,000
123,664,000
174,545,000
107,949,000
125,478,000
101,660,000
173,241,000
142,572,000
94,660,000
74,900,906
57,729,750
29,748,593
45,829,695
53,272,659
13,433,071
1,035,457
175,102
650,507
1,958,784
1,521,589
1,071,545
1,496,081
1,941,375
1,677,484
5,678,644
2,800,000
6,700,000
3,000,000
3,600,000
5,900,000
3,500,000
4,800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.